Legalization of medical cannabis approved by the Polynesian Assembly

The legalization of medical cannabis in Fenua is making great strides. Representatives of the Assembly of Polynesia recently approved the bill regulating «certain activities related to cannabis without narcotic properties and medicines containing cannabis or cannabinoids», with 41 votes in favor and 16 abstentions. This legislative initiative is in line with the commitment made by Moetai Brotherson to ensure that patients who need it have access to the therapeutic cannabis by the end of 2024.

Regulatory framework and implementation

Approved legislation lays the foundations for the cultivation and regulation of cannabis, by focusing initially on a pilot phase. This initial phase will involve a limited number of industrial players in order to define the types of products to be prescribed before extending the sector to others.

The Polynesian Hemp Syndicate (SPC), headed by Philippe Cathelain, was one of the main advocates of this breakthrough. Mr Cathelain expressed his satisfaction with the Assembly's decision, acknowledging the considerable efforts made over four years to reach this milestone. He pointed out that while the initial text is not perfect, it is an essential starting point that will enable amendments and improvements to be made through practical testing.

https://twitter.com/SPC_TAHITI/status/1810948677273367029

Distinction between therapeutic cannabis and CBD

The bill, backed by the Ministries of Health and Agriculture, draws a clear distinction between medical cannabis and wellness hemp. This distinction is based on French legislation, which allows maximum THC content of 0.3% in the plant and in the finished product.

Health Minister Cedric Mercadal stressed the importance of semantic clarity so that the public understands that the legislation does not authorize recreational use, but rather aims to provide optimum medical assistance to patients.

The new legislation includes a plan for a local cannabis production chain from THC-free seeds, managed by «controlled farmers» to guarantee a product free from pesticides and heavy metals, suitable in particular for CBD production. The Council of Ministers will be responsible for determining the perimeters, locations and specific cultivation methods through successive decrees. This controlled approach is designed to guarantee the safety and quality of cannabis products made available to patients.

Nicole Sanquer, representing non-affiliates, proposed that the law be reviewed after one year to assess its impact and effectiveness. Cédric Mercadal agreed, stressing the need for ongoing evaluation to measure the benefits for patients and the production sector, ensuring proper management of resources and regulations.